|
1
|
McGarry KA and Kiel DP: Postmenopausal
osteoporosis. Strategies for preventing bone loss, avoiding
fracture. Postgrad Med. 108:79–82. 85–88. 912000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hertrampf T, Gruca MJ, Seibel J, et al:
The bone-protective effect of the phytoestrogen genistein is
mediated via ER alpha-dependent mechanisms and strongly enhanced by
physical activity. Bone. 40:1529–1535. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Negishi-Koga T, Shinohara M, Komatsu N, et
al: Suppression of bone formation by osteoclastic expression of
semaphorin 4D. Nat Med. 17:1473–1481. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Uccelli A, Moretta L and Pistoia V:
Mesenchymal stem cells in health and disease. Nat Rev Immunol.
8:726–736. 2008. View
Article : Google Scholar
|
|
5
|
Liu Y, Wang L, Kikuiri T, et al:
Mesenchymal stem cell-based tissue regeneration is governed by
recipient T lymphocytes via IFN-γ and TNF-α. Nat Med. 17:1594–1601.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rodan GA and Martin TJ: Therapeutic
approaches to bone diseases. Science. 289:1508–1514. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Teitelbaum SL: Osteoclasts: what do they
do and how do they do it? Am J Pathol. 170:427–435. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Riggs BL and Hartmann LC: Selective
estrogen-receptor modulators - mechanisms of action and application
to clinical practice. N Engl J Med. 348:618–629. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Couse JF and Korach KS: Estrogen receptor
null mice: what have we learned and where will they lead us? Endocr
Rev. 20:358–417. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shang Y and Brown M: Molecular
determinants for the tissue specificity of SERMs. Science.
295:2465–2468. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mangelsdorf DJ, Thummel C, Beato M, et al:
The nuclear receptor superfamily: the second decade. Cell.
83:835–839. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Belandia B and Parker MG: Nuclear
receptors: a rendezvous for chromatin remodeling factors. Cell.
114:277–280. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ming LG, Chen KM and Xian CJ: Functions
and action mechanisms of flavonoids genistein and icariin in
regulating bone remodelling. J Cell Physiol. 228:513–521. 2013.
View Article : Google Scholar
|
|
14
|
Chen KM, Ge BF, Ma HP, et al: Icariin, a
flavonoid from the herb Epimedium enhances the osteogenic
differentiation of rat primary bone marrow stromal cells.
Pharmazie. 60:939–942. 2005.
|
|
15
|
Chen KM, Ma HP, Ge BF, et al: Icariin
inhibits the osteoclast formation induced by RANKL and
macrophage-colony stimulating factor in mouse bone marrow culture.
Pharmazie. 62:388–391. 2007.PubMed/NCBI
|
|
16
|
Yamaza T, Miura Y, Bi Y, et al:
Pharmacologic stem cell based intervention as a new approach to
osteoporosis treatment in rodents. PLoS One. 3:e26152008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hsieh TP, Sheu SY, Sun JS and Chen MH:
Icariin inhibits osteoclast differentiation and bone resorption by
suppression of MAPKs/NF-κB regulated HIF-1α and PGE(2) synthesis.
Phytomedicine. 18:176–185. 2011. View Article : Google Scholar
|
|
18
|
Huang J, Yuan L, Wang X, et al: Icaritin
and its glycosides enhance osteoblastic, but suppress osteoclastic,
differentiation and activity in vitro. Life Sci. 81:832–840. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhai YK, Ge BF and Ma HP: Comparative
study on the osteogenic differentiation of rat bone marrow stromal
cells effected by icariin and icariside II. Zhong Yao Cai.
33:1896–1900. 2010.In Chinese.
|
|
20
|
Zhai YK, Ge BF and Ma HP: Icariin promotes
osteogenic differentiation of rat bone marrow stromal cells in
vitro. Zhongguo Zhong Yao Za Zhi. 35:3219–3222. 2010.In
Chinese.
|
|
21
|
Ma HP, Ming LG and Ge BF: Icariin is more
potent than genistein in promoting osteoblast differentiation and
mineralization in vitro. J Cell Biochem. 112:916–923. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ming LG, Zhou J, Cheng GZ, et al: Osthol,
a coumarin isolated from common cnidium fruit, enhances the
differentiation and maturation of osteoblasts in vitro.
Pharmacology. 88:33–43. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mok SK, Chen WF and Lai WP: Icariin
protects against bone loss induced by oestrogen deficiency and
activates oestrogen receptor-dependent osteoblastic functions in
UMR 106 cells. Br J Pharmacol. 159:939–949. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Powell ME and Smith MJ: The determination
of serum acid and alkaline phosphatase activity with
4-aminoantipyrine (A.A.P.). J Clin Pathol. 7:245–248. 1954.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nian H, Ma MH, Nian SS and Xu LL:
Antiosteoporotic activity of icariin in ovariectomized rats.
Phytomedicine. 16:320–326. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang ZB and Yang QT: The testosterone
mimetic properties of icariin. Asian J Androl. 8:601–605. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ning H, Xin ZC, Lin G, et al: Effects of
icariin on phosphodies-terase-5 activity in vitro and cyclic
guanosine monophosphate level in cavernous smooth muscle cells.
Urology. 68:1350–1354. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dell’Agli M, Galli GV, Dal Cero E, et al:
Potent inhibition of human phosphodiesterase-5 by icariin
derivatives. J Nat Prod. 71:1513–1517. 2008. View Article : Google Scholar
|
|
29
|
Xu HB and Huang ZQ: Icariin enhances
endothelial nitric-oxide synthase expression on human endothelial
cells in vitro. Vascul Pharmacol. 47:18–24. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bian Q, Huang JH, Liu SF, et al: Different
molecular targets of icariin on bMSCs in CORT and OVX-rats. Front
Biosci (Elite Ed). 4:1224–1236. 2012. View
Article : Google Scholar
|
|
31
|
Barkhem T, Haldosén LA, Gustafsson JA and
Nilsson S: Transcriptional synergism on the pS2 gene promoter
between a p160 coactivator and estrogen receptor-alpha depends on
the coactivator subtype, the type of estrogen response element, and
the promoter context. Mol Endocrinol. 16:2571–2581. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zampese E, Fasolato C, Pozzan T and Pizzo
P: Presenilin-2 modulation of ER-mitochondria interactions: FAD
mutations, mechanisms and pathological consequences. Commun Integr
Biol. 4:357–360. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hsieh TP, Sheu SY, Sun JS, et al: Icariin
isolated from Epimedium pubescens regulates osteoblasts anabolism
through BMP-2, SMAD4, and Cbfa1 expression. Phytomedicine.
17:414–423. 2011. View Article : Google Scholar
|
